August 26, 2016
The four direct oral anticoagulants (DOACs) are difficult to clearly distinguish from each other in terms of safety and efficacy. Each company has adopted different marketing policies for its product. Let’s look at the indication of pulmonary thromboembolism/deep vein thromboembolism...read more